When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
TAK - Centogene extends partnership with Takeda in diagnosis of genetic disorders
Takeda Pharmaceutical Company Limited American Depositary Shares
Centogene (CNTG) has extended its partnership with Takeda Pharmaceutical (TAK) to diagnose patients with certain genetic disorders. As part of the agreement, which has been extended until March 2022, Centogene will continue providing access to genetic testing to patients around the world. In January 2015, CNTG originally inked agreement with Shire Pharmaceuticals, which is now a subsidiary of Takeda, to provide diagnostic testing capability to enhance early diagnosis of patients suffering from genetic rare diseases.